These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 14194728)

  • 61. [STUDIES ON MYCOBACTERIAL SENSITIVITY TO ANTIBIOTICS AND CHEMOTHERAPEUTIC AGENTS].
    DYKHNO MM; KOCHEMASOVA ZN; DOROZHKOVA IR
    Antibiotiki; 1963 Jul; 8():597-601. PubMed ID: 14090358
    [No Abstract]   [Full Text] [Related]  

  • 62. THE CLINICAL SIGNIFICANCE OF PRIMARY DRUG RESISTANCE IN TUBERCULOSIS AS JUDGED IN A MILITARY POPULATION, 1960-1963.
    LEDWITH JW
    Am Rev Respir Dis; 1964 Oct; 90():516-23. PubMed ID: 14221664
    [No Abstract]   [Full Text] [Related]  

  • 63. PRIMARY DRUG RESISTANCE AND PULMONARY TUBERCULOSIS. EMERGENCE OF PRIMARY DRUG RESISTANCE.
    RAUNIO O; ELO O
    Ann Med Intern Fenn; 1964; 53():113-22. PubMed ID: 14233850
    [No Abstract]   [Full Text] [Related]  

  • 64. CHEMOTHERAPY FOR PATIENTS WITH CULTURES RESISTANT TO STREPTOMYCIN, ISONIAZID AND PAS.
    JANCIK E; ZELENKA M; TOUSEK J; MAKOVA M
    Tubercle; 1963 Dec; 44():443-5. PubMed ID: 14101324
    [No Abstract]   [Full Text] [Related]  

  • 65. [EXPERIMENTAL STUDY OF RIFAMYCIN SV. (PRELIMINARY REPORT)].
    HERRERAMALMSTEN L; BORRASCUESTA F; HERRERACARVAJAL C
    Chemotherapia (Basel); 1963; 10():621-35. PubMed ID: 14184800
    [No Abstract]   [Full Text] [Related]  

  • 66. VARIATIONS IN MYCOBACTERIA RELATED INTIMATELY OR REMOTELY TO THE DISEASE TUBERCULOSIS.
    SWEANY HC; THOMAS JR; BOHANNAN JC; SCHOLES VE
    J Lancet; 1964 Feb; 84():47-53. PubMed ID: 14125126
    [No Abstract]   [Full Text] [Related]  

  • 67. [THE APPEARANCE OF EARLY RESISTANCE OF KOCH'S BACILLUS TO ANTIBIOTICS IN COUNTRIES WHERE TUBERCULOSIS RAGES AS AN ENDEMIC DISEASE].
    AKSUGUR H
    Rev Hyg Med Soc; 1964; 12():87-93. PubMed ID: 14132995
    [No Abstract]   [Full Text] [Related]  

  • 68. [EXPERIMENTAL STUDIES ON THE EFFECT OF SO-CALLED SECONDARY ANTITUBERCULOSIS DRUGS. (1). COMBINATION EFFECTS OF SM-INH-PAS, SM-INH-TH AND KM-TH-CS ON EXPERIMENTAL TUBERCULOSIS IN MICE].
    TAGA M
    Kekkaku; 1964 Dec; 39():543-9. PubMed ID: 14270667
    [No Abstract]   [Full Text] [Related]  

  • 69. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 70. COMPARISON OF TWO CURRENT METHODS FOR DETECTING STREPTOMYCIN AND PAS RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS.
    BURNET ME; STEWART SM
    Am Rev Respir Dis; 1964 Oct; 90():642-5. PubMed ID: 14221680
    [No Abstract]   [Full Text] [Related]  

  • 71. [ON CHARACTERISTICS OF MYCOBACTERIUM TUBERCULOSIS STRAINS IN REPEATED DIAGNOSIS].
    KUZNETSOVA KB; CHERNIGOVSKAIA NN
    Probl Tuberk; 1963; 41():57-61. PubMed ID: 14105705
    [No Abstract]   [Full Text] [Related]  

  • 72. [COMBINATION OF ETHIONAMIDE AND P-AMINOSALICYLIC ACID IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH GERMS RESISTANT TO ISONIAZID AND STREPTOMYCIN].
    PEREZ JA; FARIAS CE; AMADIO G; CAFURE N
    Prensa Med Argent; 1963 Dec; 50():3280-1. PubMed ID: 14184234
    [No Abstract]   [Full Text] [Related]  

  • 73. PRIMARY DRUG RESISTANCE: A CONTINUING STUDY OF TUBERCLE BACILLI IN A VETERAN POPULATION WITHIN THE UNITED STATES. IV. FACTORS INFLUENCING THE OBSERVED FREQUENCY OF RESISTANCE.
    HOBBY GL; JOHNSON PM; CRAWFORD-GAGLIARDI L; GREETHAM L; LENERT TF
    Am Rev Respir Dis; 1965 Apr; 91():575-82. PubMed ID: 14263936
    [No Abstract]   [Full Text] [Related]  

  • 74. ALTERNATING REGIMENS OF STREPTOMYCIN-PYAZINAMIDE, ISONIAZID-PARA-AMINOSALICYLIC ACID AT BATTEY STATE HOSPITAL.
    CORPE RF; BLALOCK FA
    Am Rev Respir Dis; 1964 Aug; 90():262-5. PubMed ID: 14198672
    [No Abstract]   [Full Text] [Related]  

  • 75. [METHOD FOR EVALUATING ANTITUBERCULAR DRUGS BY THEIR DIFFUSION INTO DEEP CULTURES OF TUBERCLE BACILLI IN SEMISOLID AGAR MEDIA].
    OKAMOTO K; FUJINAGA R; YAMAUCHI H
    Kekkaku; 1963 Sep; 38():413-7. PubMed ID: 14130758
    [No Abstract]   [Full Text] [Related]  

  • 76. [TUBERCULOUS MENINGITIS WITH RESISTANT KOCH BACILLI; RECOVERY OWING TO CYCLOSERINE-PYRAZINAMIDE COMBINATION].
    FOUQUET J; CORNU P
    Arch Fr Pediatr; 1964 Dec; 21():1217-21. PubMed ID: 14248329
    [No Abstract]   [Full Text] [Related]  

  • 77. MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.
    CANETTI G; FROMAN S; GROSSET J; HAUDUROY P; LANGEROVA M; MAHLER HT; MEISSNER G; MITCHISON DA; SULA L
    Bull World Health Organ; 1963; 29(5):565-78. PubMed ID: 14102034
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [TREATMENT OF TUBERCULOUS PATIENTS EXPECTORATING, MYCOBACTERIUM TUBERCULOSIS RESISTANT TO ANTIBIOTICS].
    KORNIENKO VT
    Probl Tuberk; 1964; 42():17-24. PubMed ID: 14242843
    [No Abstract]   [Full Text] [Related]  

  • 79. [ATYPICAL MYCOBACTERIA OF HUMAN ORIGIN. (REPORT OF 2 CASES)].
    CUCCHIANIACEVEDO RA; FIORINO A; NIKOLAJUKDEIRURZUN R
    Rev Asoc Med Argent; 1964 Feb; 78():66-8. PubMed ID: 14139791
    [No Abstract]   [Full Text] [Related]  

  • 80. [COMPARISON OF A DETERMINATION OF DRUG RESISTANCE USING 1 PER CENT OGAWA MEDIUM AND LOEWENSTEIN-JENSEN MEDIUM (EXAMINATION OF SPUTUM)].
    TSUKAMURA S
    Kekkaku; 1964 Feb; 39():60-3. PubMed ID: 14136876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.